RecruitingPhase 4NCT07704255
Study on the Effect of Fecal Microbiota Transplantation on Eradication of Refractory Helicobacter Pylori Infection
Sponsor
Sichuan Provincial People's Hospital
Enrollment
10 participants
Start Date
Jul 20, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
To determine whether regulating the gut microbiota can contribute to the eradication of refractory H. pylori infection.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a biological treatment called transanal fecal bacteria transplant for people with helicobacter pylori infection. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALtransanal fecal bacteria transplant
Received transanal fecal bacteria transplant
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07704255
Related Trials
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
NCT066603421 location
VA Dual Sequential Therapy
NCT069299621 location
Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion
NCT057629911 location
Effect of PPIs on Stool DNA Test for H. Pylori
NCT075162621 location
Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication
NCT074394451 location